Literature DB >> 20148746

The effectiveness of intermittent rat parathyroid hormone (1-34) treatment on low bone mass due to oestrogen or androgen depletion in skeletally mature rats.

M Montero1, D Serfati, S Luna, M Díaz-Curiel, M T Carrascal, S Gomez, C De la Piedra.   

Abstract

Rat parathyroid hormone (PTH) 1-34 (4 microg/kg/day) was applied for 2.5 months to 9 month-old rats immediately after ovariectomy or orchidectomy or to 15 month-old rats with low bone mass which had been castrated 6 months before in order to know the effects on serum biochemistry parameters, lumbar and femoral bone mineral density, histology, cancellous and cortical bone histomorphometry, mineralisation content profile in cortical bone by backscattered-electron microscopy, and femoral torsion biomechanical testing. In ovariectomised rats, preventive PTH treatment avoided cancellous bone loss in tibial metaphysis and partially in lumbar vertebra, while in cortical bone, PTH increased endosteal resorption and periosteal formation. In intervention study, PTH did not restore cancellous bone but a strong endosteal and periosteal new bone formation was detected. In orchidectomised rats, PTH, in preventive study, avoided cancellous bone loss in metaphysis and lumbar vertebra, and a mild new bone formation in cortical bone was found. In intervention study, PTH maintained baseline cancellous bone mass, but in cortical bone a strong endosteal and periosteal new bone formation was detected. The PTH-induced new bone formation was confirmed by histology and by mineral content profiles. After castration, biomechanical properties were affected in females but not in male rats and PTH reverted this effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148746     DOI: 10.3109/13685530903536650

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  2 in total

1.  Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.

Authors:  Erik R Sampson; Matthew J Hilton; Ye Tian; Di Chen; Edward M Schwarz; Robert A Mooney; Susan V Bukata; Regis J O'Keefe; Hani Awad; J Edward Puzas; Randy N Rosier; Michael J Zuscik
Journal:  Sci Transl Med       Date:  2011-09-21       Impact factor: 17.956

2.  Modifications in bone matrix of estrogen-deficient rats treated with intermittent PTH.

Authors:  Rafael Pacheco-Costa; Jenifer Freitas Campos; Eduardo Katchburian; Valquíria Pereira de Medeiros; Helena Bonciani Nader; Keico Okino Nonaka; Lilian Irene Plotkin; Rejane Daniele Reginato
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.